RECRUITING

iMOVE: Virtual Reality PT Versus Traditional PT

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This pragmatic, crossover, randomized controlled study evaluates the efficacy of virtual reality assisted physical therapy (VRPT) for improving the physical activity of hospitalized children as compared to traditional physical therapy. This is a pilot study that will be used to identify patient populations that can benefit the most from VRPT and estimate this effect for future studies. Patients with a significant neurological condition, major developmental disability, active infection of the face or hand, history of severe motion sickness, history of seizures caused by flashing light or had a major surgery within the last 48 hours will be excluded.

Official Title

Immersive Virtual Reality for Enhancement of Physical Activity in Pediatric Oncology : a Randomised Control Study (iMOVE)

Quick Facts

Study Start:2025-06-01
Study Completion:2026-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05876156

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:10 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Between age 10-25 years
  2. * Diagnosed with cancer
  3. * Has an active physical therapy consultation
  4. * Anticipated inpatient stay for at least 3-days with the second PT session following between 24-72 hours after the first PT session
  5. * Ability to understand and the willingness to personally sign the written Institutional Review Board (IRB) approved informed consent document by Legally Authorized Representative (LAR) if participant \<18 years old or by participant if 18+
  6. * Ability to understand and the willingness to personally sign the written IRB approved informed assent document for patient \<18 years old.
  1. * Legal guardian does not present to obtain consent.
  2. * Child with a significant neurological condition, or major developmental disability.
  3. * Child with active infection of the face or hand.
  4. * A history of severe motion sickness.
  5. * A history of seizures caused by flashing light.
  6. * Major surgery within the last 48 hours.
  7. * Does not speak English (required for surveys)
  8. * With visual impairments or any degree of developmental delays
  9. * Child on mechanical ventilation or ventilatory support

Contacts and Locations

Study Contact

Thomas Caruso
CONTACT
650-723-5728
tjcaruso@stanford.edu
Man Yee Suen
CONTACT
650-723-5728
smy822@stanford.edu

Principal Investigator

Thomas Caruso
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Lucile Packard Childrens Hospital Stanford
Palo Alto, California, 94304
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Thomas Caruso, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-01
Study Completion Date2026-05-31

Study Record Updates

Study Start Date2025-06-01
Study Completion Date2026-05-31

Terms related to this study

Keywords Provided by Researchers

  • Virtual Reality
  • Physical Activity

Additional Relevant MeSH Terms

  • Physical Health